Policy and practice in healthcare systems to promote biosimilar use
Biologics, biologicals, or biotherapeutics are biologically derived protein-based therapeutic agents that differ from chemically synthesized small-molecule drugs in terms of the molecular complexity and production process. Starting with insulin for diabetes treatment, biologicals have transformed the treatments for several common and/or serious diseases.3 Approximately 25% of all newly approved medicines and one in development are…